| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |